Skip to main content

Table 5 Chemotherapeutic response according to LMR_SUV scores

From: Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

SUV_LMR score PR + CR SD + PD ORR Compared p value p value
Score 0 (n = 36) 32 4 88.9% Score 1 0.002** < 0.001***
    Score 2 < 0.001***  
Score 1 (n = 57) 34 23 59.6% Score 2 < 0.001***  
Score 2 (n = 56) 14 42 25.0%    
  1. SUV standardized uptake value, LMR lymphocyte-monocyte ratio, CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR objective response rate. *, p < 0.05; **, p < 0.01; ***, p < 0.001